TCTMD (@TCTMD) header
TCTMD (@TCTMD) profile picture

TCTMD

@TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at https://teapawt.net/t.co/9j3KOiiahQ

 New York, NY
tctmd.com
Joined May 2009
  • Tweets21.1K
  • Following6.6K
  • Followers28.3K
8.3KMedia
Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)
Guiding DAPT De-escalation With Platelet Function Testing Doesn’t Improve Outcomes: EPIC17-VERONICA bit.ly/4kRsHiB
Image from TCTMD (@TCTMD)
2
3
505
Can targeting inflammation still reduce cardiovascular events? ZEUS found no benefit with ziltivekimab, but experts say the inflammatory hypothesis may not be finished. bit.ly/4sXU2lt
Image from TCTMD (@TCTMD)
457
Unhoused PAD Patients Require Nuanced Care, Data Suggest bit.ly/3UM0Eqp
Image from TCTMD (@TCTMD)
453
Lp(a)HORIZON did not show the hoped-for cardiovascular benefits of reducing lipoprotein(a). Still, experts caution that one neutral trial does not end the pursuit of effective Lp(a)-lowering therapies. bit.ly/4iQa0t9
Image from TCTMD (@TCTMD)
2
631
SCOUT-HCM: Mavacamten Maintains Benefits Through 56 Weeks bit.ly/4zK4W0w
Image from TCTMD (@TCTMD)
359
This year's TCT Shark Tank winner, Loïc Van Horne, shares details about how Narwhal Medical created a blood pump designed for delivery through the radial artery. Hear more about the technology and vision behind its development in this TCTMD interview: bit.ly/4jeBglt
561
Widespread CPR Training Effort Didn’t Nudge OHCA Outcomes: RACE-CARS bit.ly/4zJuv1K
Image from TCTMD (@TCTMD)
1
2
6
936
TCT 2026: New data and key takeaways for Paradise uRDN. Visit: bit.ly/48vfGE3 Explore real-world experience, four-year durability, sedation, hospital economics, and patient-centric analysis. Sponsored by @RecorMedical #Sponsored
Image from TCTMD (@TCTMD)
1
391
Did you guess correctly? This week's episode features Nicolas Van Mieghem! Listen to the full episode for more on his guiding mantra in life, his effort to maintain a balance between ambition and family, and more: bit.ly/3WBuY7G @drnvanmieghem @TCTMD_Yael
Image from TCTMD (@TCTMD)
1
466
Good Outcomes Maintained at 2 Years With Sapien M3 TMVR: ENCIRCLE bit.ly/3WuGUbn
Image from TCTMD (@TCTMD)
1
2
673
The conversations from #TCT2026 keep coming. Mamas Mamas speaks with Rebecca Hahn about Australian data on severe tricuspid regurgitation and what it means for treatment decisions. Catch the full conversation behind the data, and stay tuned as our coverage continues: bit.ly/4AtpR8g
1
604
How much autonomy should AI be given? Tony Das and Aasif Qasim discuss the possibilities and areas of concern that were highlighted during a #TCT2026 session.
1
1
537
During Elective PCI, High- and Low-Dose Heparin Provide Similar Outcomes bit.ly/4iLNCB0
Image from TCTMD (@TCTMD)
8
1,107
The FDA has approved asundexian for secondary stroke prevention, bringing a new class of oral anticoagulant to the market. High cost may be an initial barrier to uptake. Read TCTMD’s full coverage here: bit.ly/4zd1N8q
The image features a red rectangular stamp with the word "APPROVED" centered on a geometric, abstract blue background.

ALT The image features a red rectangular stamp with the word "APPROVED" centered on a geometric, abstract blue background.

2
3
558
#TCT2026 coverage continues! @mirvatalasnag shares insight from a session discussing how to overcome barriers to MedTech on the global scale and reveals how inclusivity is essential to improving access. For all the latest news from TCT, click here: tctmd.com/TCT2026
4
4
470
ANGPTL4-Targeting Drug for High Triglycerides Moves Ahead: TYDAL-TIMI 78 bit.ly/4BSYVA8
Image from TCTMD (@TCTMD)
1
5
787
We're back with another guessing game! This month's guest joined us for a conversation at #TCT2026. Who do you think @TCTMD_Yael spoke to this time? Stay tuned to listen AND watch this episode on Wednesday to find out.
A silhouette with a question mark is centered, surrounded by icons and text. On the left: "Belgium," "Mens sana in corpore sano," and "TAVI." On the right: "Digital education," "Ambition-Family Balance," and "Swimming." The background features outlines of a heart and brain, with a "Hearts & Minds" logo in the corner.

ALT A silhouette with a question mark is centered, surrounded by icons and text. On the left: "Belgium," "Mens sana in corpore sano," and "TAVI." On the right: "Digital education," "Ambition-Family Balance," and "Swimming." The background features outlines of a heart and brain, with a "Hearts & Minds" logo in the corner.

1
2
399
Better Outcomes With LBB vs RV Pacing for Atrioventricular Block bit.ly/4iL81q7
A person stands at a podium on stage delivering a presentation at the American Heart Association Scientific Sessions. The presentation slide reads "LEFT BUNDLE BRANCH PACING VERSUS RIGHT VENTRICULAR PACING FOR ATRIOVENTRICULAR BLOCK: OptimizePacing Trial." The background features a large red and white design with the event's branding.

ALT A person stands at a podium on stage delivering a presentation at the American Heart Association Scientific Sessions. The presentation slide reads "LEFT BUNDLE BRANCH PACING VERSUS RIGHT VENTRICULAR PACING FOR ATRIOVENTRICULAR BLOCK: OptimizePacing Trial." The background features a large red and white design with the event's branding.

1
3
822
Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users bit.ly/4Bloo52
Image from TCTMD (@TCTMD)
1
558
On-Duty Firefighter Deaths Are Increasingly Cardiac in Nature bit.ly/47HW3s7
Image from TCTMD (@TCTMD)
1
537
Load more